Prospective, Observational, Non-Interventional, Multicentre Study on the Efficacy and Tolerability of a New Calcipotriol/Betamethasone Aerosol Foam (Enstilar®) in Patients with Plaque Psoriasis under Daily Practice Conditions | Zendy

Sascha Gerdes | Zendy; Marion Krakor | Zendy; Tobias Anger | Zendy; Hans Hütt | Zendy; Andreas Körber | Zendy

Open Access

Prospective, Observational, Non-Interventional, Multicentre Study on the Efficacy and Tolerability of a New Calcipotriol/Betamethasone Aerosol Foam (Enstilar®) in Patients with Plaque Psoriasis under Daily Practice Conditions

Author(s) -

Sascha Gerdes,

Marion Krakor,

Tobias Anger,

Hans Hütt,

Andreas Körber

Publication year - 2017

Publication title -

dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.224

H-Index - 92

eISSN - 1421-9832

pISSN - 1018-8665

DOI - 10.1159/000486700

Subject(s) - tolerability , medicine , psoriasis , calcipotriol , betamethasone dipropionate , observational study , adverse effect , dermatology , dosing , plaque psoriasis , prospective cohort study , betamethasone

To assess the efficacy and tolerability of the new aerosol foam of calcipotriol 50 µg/g plus betamethasone dipropionate 0.5 mg/g (Cal/BD foam, Enstilar®) in psoriasis vulgaris under daily practice conditions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research